PMID: 11920527Mar 29, 2002Paper

Metastatic nonseminomatous germ cell tumors of the testis: results of elective and salvage surgery for patients with residual retroperitoneal masses

Cancer
W F HendryA Horwich

Abstract

A mass may persist in the para-aortic region after patients undergo chemotherapy for metastatic, nonseminomatous germ cell tumor of the testis (NSGCT). Retroperitoneal lymphadenectomy removes the mass, which may contain residual active malignancy, and allows histologic assessment of the effectiveness of the chemotherapy. Whereas some have favored early, elective removal of such masses, others have chosen to observe them, reserving salvage surgery for patients who experience disease recurrence. A retrospective analysis was undertaken to define the outcome in these two groups of patients. After receiving chemotherapy for metastatic NSGCT, 442 men underwent lymphadenectomy for residual masses (measuring > or = 1 cm in greatest dimension) between 1976 and 1999, inclusive. Three hundred thirty men underwent elective surgery within 3 months of the completion of chemotherapy, and 112 men underwent salvage surgery after receiving reinduction chemotherapy for tumor recurrence. The residual mass was removed completely in 87% and 72% of patients in the elective and salvage lymphadenectomy groups, respectively; was removed with difficulty and possibly incompletely in 9% and 21% of patients, respectively; and was definitely removed incomple...Continue Reading

References

Jan 1, 1977·The Journal of Urology·L H Einhorn, J P Donohue
Jan 1, 1977·British Journal of Urology·W F HendryM J Peckham
Feb 1, 1991·The British Journal of Surgery·R P KulkarniK D Bagshawe
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D P DearnaleyM J Peckham
Jun 1, 1989·British Journal of Urology·S N WilliamsJ P Blandy
Dec 1, 1989·European Journal of Cancer & Clinical Oncology·M J HardingS B Kaye
Jan 1, 1985·The British Journal of Surgery·M D LevittM J Byrne
May 24, 1986·Lancet·R Kuzmits, H Ludwig
Oct 31, 1987·British Medical Journal·S Chan, K Sikora
May 7, 1983·Lancet·L J GeierJ Redmond
Mar 1, 1981·The Journal of Urology·J P Donohue, R G Rowland
Oct 15, 1982·Cancer·C J LogothetisD E Johnson
Jan 1, 1983·The Journal of Urology·R B BrackenM L Samuels
Jun 1, 1982·The Journal of Urology·D G SkinnerG Lieskovsky
Jan 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·W F Hendry
May 1, 1995·British Journal of Cancer·A Horwich
Jan 1, 1993·European Urology·D R JonesW F Hendry
Jan 6, 1999·The Annals of Thoracic Surgery·D LiuR J Ginsberg
Aug 12, 1999·The Laryngoscope·E C Weisberger, L C McBride
Nov 24, 1999·Annals of Surgical Oncology·T L HahnR J Goulet
Dec 22, 1999·International Journal of Cancer. Journal International Du Cancer·M KuczykU Jonas
Dec 22, 1999·International Journal of Cancer. Journal International Du Cancer·E W SteyerbergJ D Habbema
Aug 17, 2000·British Journal of Cancer·J S de BonoS B Kaye

❮ Previous
Next ❯

Citations

Sep 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·O RickJ Beyer
Sep 28, 2004·World Journal of Urology·J R SpermonL A L M Kiemeney
Oct 5, 2011·Therapeutic Advances in Urology·Siamak DaneshmandCraig Nichols
Aug 13, 2011·Der Urologe. Ausg. A·S Krege
Aug 2, 2012·Therapeutic Advances in Urology·Axel Heidenreich, David Pfister
Apr 11, 2014·The Oncologist·Stephen B RiggsDerek Raghavan
May 18, 2018·Oncology Research and Treatment·Axel HeidenreichDavid Pfister
Aug 13, 2002·Current Opinion in Urology·Peter Albers
Mar 10, 2005·Der Urologe. Ausg. A·M KuczykJ Beyer
Mar 3, 2009·Der Urologe. Ausg. A·A HeidenreichR Souchon
Aug 19, 2010·Der Urologe. Ausg. A·D PfisterA Heidenreich
Sep 29, 2011·Annals of the Royal College of Surgeons of England·N HaldipurJ D Beard
Jul 16, 2009·World Journal of Urology·Stephen D W Beck, Richard S Foster
Aug 20, 2008·Expert Opinion on Pharmacotherapy·C KollmannsbergerC Bokemeyer
Jul 28, 2011·International Journal of Andrology·D KoychevF Honecker
Oct 19, 2017·Nature Reviews. Clinical Oncology·Min Yuen TeoHoward I Scher
Jan 23, 2019·Current Oncology Reports·Costantine AlbanyClint Cary
Aug 30, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jan OldenburgSophie D Fossa
Jun 5, 2003·Current Opinion in Oncology·Beth A Hellerstedt, Kenneth J Pienta
Aug 8, 2008·Current Opinion in Supportive and Palliative Care·Christian Kollmannsberger, Carsten Bokemeyer
Apr 18, 2009·World Journal of Urology·Jan OldenburgSophie D Fosså
Mar 11, 2005·Expert Review of Anticancer Therapy·Robert A Huddart, Alison J Birtle
May 14, 2014·Nature Reviews. Urology·Christian BachAnthony Koupparis
Feb 23, 2019·Expert Review of Anticancer Therapy·Axel HeidenreichDavid Pfister
Jan 10, 2020·International Journal of Urology : Official Journal of the Japanese Urological Association·Hiroaki TsunezukaMasayoshi Inoue
Oct 21, 2009·BJU International·Jan Oldenburg, Sophie D Fosså
Dec 21, 2010·Expert Review of Anticancer Therapy·Michael C Risk, Richard S Foster
Oct 21, 2009·BJU International·Christian WinterPeter Albers
May 27, 2014·American Society of Clinical Oncology Educational Book·Hege Sagstuen HaugnesDarren Richard Feldman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.